Signos has 6 close competitors: Benchling, Commure, Doctolib.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
SignosBenchlingCommureDoctolibSolugenAbridgeSave 25% with code AUGUST25 at checkout.
Signos competes with 6 companies here: Benchling, Commure, Doctolib, Solugen, Abridge, Alloy Therapeutics.
Signos was last valued at $1B (post-money, May 2026). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $1B (post-money, May 2026).
Lead investors for each round are in the funding timeline.
The closest healthtech / diabetes peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
